Listex is a technology company that does not distribute products, that's why there is no opportunity to buy or sell any goods on this site.

Claritin-D Non-Drowsy Indoor & Outdoor Allergies Extended Release 24 Hour Tablets - 5 CT
Claritin-D Non-Drowsy Indoor & Outdoor Allergies Extended Release 24 Hour Tablets - 5 CT
Claritin-D Non-Drowsy Indoor & Outdoor Allergies Extended Release 24 Hour Tablets - 5 CT
Claritin-D Non-Drowsy Indoor & Outdoor Allergies Extended Release 24 Hour Tablets - 5 CT
Claritin-D Non-Drowsy Indoor & Outdoor Allergies Extended Release 24 Hour Tablets - 5 CT
Claritin-D Non-Drowsy Indoor & Outdoor Allergies Extended Release 24 Hour Tablets - 5 CT
Claritin-D Non-Drowsy Indoor & Outdoor Allergies Extended Release 24 Hour Tablets - 5 CT
Claritin-D Non-Drowsy Indoor & Outdoor Allergies Extended Release 24 Hour Tablets - 5 CT
The product has not been verified
Product information may be out of date
Product barcodes

Characteristics Claritin-D Non-Drowsy Indoor & Outdoor Allergies Extended Release 24 Hour Tablets - 5 CT.

ItemMaster Dimensions
Length, IN 1.275
Height, IN 3.043
Width, IN 4.441
Weight, LB 0.05
special attributes
Units In Package 5
Package Type BOX
Package Size, CT 5.0
Seasonal N
Ingredients Active ingredients (in each Tablet) - Purpose. Loratadine 10 mg - Antihistamine. Pseudoephedrine Sulfate 240mg - Nasal Decongestant. Inactive Ingredients: Carnauba Wax, Dibasic Calcium Phosphate Dihydrate, Ethylcellulose, Hydroxypropyl Cellulose, Hypromellose, Magnesium Stearate, Pharmaceutical Ink, Polyethylene Glycol, Povidone, Silicon Dioxide, Sucrose, Titanium Dioxide.
Recycle Codes Y
Temperature Indicator Shelf Stable
Ndc Code 11523-4332-1
Directions Do not divide, crush, chew or dissolve the tablet. Adults and children 12 years and over - 1 tablet daily with a full glass of water; not more than 1 tablet in 24 hours. Children under 12 years of age - ask a doctor. Consumers with liver or kidney disease - ask a doctor. Other information: Each tablet contains: calcium 25mg. Safety sealed: Do not use if the individual blister unit imprinted with Claritin-D® 24 hour is open or torn. Store between 20 degrees C to 25 degrees C (68 degrees F to 77 degrees F). Protect from light and store in a dry place.
Marketing Description Claritin-D® Non-Drowsy* Indoor & Outdoor Allergies Extended Release Tablets 24 Hour Tablets. Allergy & congestion. Pseudoephedrine sulfate 240 mg/nasal decongestant loratadine 10 mg/antihistamine. Relief of: Nasal & sinus congestion due to colds or allergies. Sneezing; Runny nose; itchy, watery eyes; itchy throat or nose due to allergies. *When taken as directed. See drug facts panel.
Other Description Uses: Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: Sneezing. Itchy, watery eyes. Runny nose. Itching of the nose or throat. Temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies. Reduces swelling of nasal passages. Temporarily relieves sinus congestion and pressure. Temporarily restores freer breathing through the nose. A subsidiary of Merck & Co., Inc., Whitehouse Station, NJ USA. All rights reserved. The graphics on the front panel of this carton constitute trademarks of MSD Consumer Care, Inc. Recyclable carton. Questions or comments? 1-800-CLARITIN (1-800-252-7484) or www.claritin.com. © copyright & distributed by MSD Consumer Care, Inc.
Ecommerce Description Claritin-D® Non-Drowsy Indoor & Outdoor Allergies Extended Release 24 Hour Tablets. Temporarily relieves symptoms like nasal congestion, sneezing, itchy, watery eyes, runny nose, itching of the nose or throat due to hay fever or other upper respiratory allergies. Reduces swelling of nasal passages. Temporarily relieves sinus congestion & pressure and restores freer breathing through the nose.
Reviews and questions about Claritin-D Non-Drowsy Indoor & Outdoor Allergies Extended Release 24 Hour Tablets - 5 CT
Log in to leave a review:
Subscribe to new reviews
Subscribe to new reviews
Further instructions are sent to the specified Email
Subscribe to the newsletter